Diabetes

Risk of Diabetes May Increase After Cancer Diagnosis

Risk of Diabetes May Increase After Cancer Diagnosis

By

Many studies have suggested that diabetes is a risk factor for the development of cancer, but whether or not cancer itself can increase the risk of diabetes requires further investigation.

Diabetes Treatments

Common oral medications used to treat diabetes mellitus.

Diabetes Ups Kidney Cancer Risk in Women

Diabetes Ups Kidney Cancer Risk in Women

By

Women with type 2 diabetes have a 1.5-fold higher risk of renal cell carcinoma compared with non-diabetic women.

Insulin Pen Devices

Insulin Pen Devices comparison chart for patients with diabetes mellitus.

Hormone Therapy for Breast Cancer May Cause Diabetes

Hormone Therapy for Breast Cancer May Cause Diabetes

By

It was unknown whether breast cancer treatment plays a causal role in the onset of diabetes.

High BMI and Diabetes May Be Increasing Global Cancer Burden

High BMI and Diabetes May Be Increasing Global Cancer Burden

By

Of 14,067,894 reported cancer cases in 2012, 280,100 (2%) were attributed to diabetes alone, 544,300 (3.9%) were attributed to a high BMI alone, and 792,600 (5.6%) were attributed to both.

Long-term Insulin Glargine-use May Increase Breast Cancer Risk

Long-term Insulin Glargine-use May Increase Breast Cancer Risk

By

Previous studies investigating the association of long-acting insulin analogues and increased breast cancer risk have been mixed, and the follow-up periods for these studies have been too short to lead to definitive conclusions.

Diabetes Linked to Increased Cancer, Cardiovascular Disease

Diabetes Linked to Increased Cancer, Cardiovascular Disease

Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes.

Age and Diabetes Linked With Neuropathy for Patients Undergoing Chemotherapy

Age and Diabetes Linked With Neuropathy for Patients Undergoing Chemotherapy

By

Age and history of diabetes may independently be predictors for the development of chemotherapy-induced peripheral neuropathy.

In the Clinic: Metformin and Pancreatic Cancer

In the Clinic: Metformin and Pancreatic Cancer

By

Metformin, traditionally used as a first-line treatment for type 2 diabetes, may be able to reduce a potential source of energy for certain cancer cells.

Metformin Use May Improve Survival in Patients With Breast Cancer, Diabetes

Metformin Use May Improve Survival in Patients With Breast Cancer, Diabetes

By

The use of metformin in standard cancer therapy may improve both overall and cancer-specific survival of patients with diabetes and breast cancer.

Statin Use May Lower Risk for Pancreatic Cancer

Statin Use May Lower Risk for Pancreatic Cancer

By

Statin use may be associated with a decreased risk of pancreatic cancer in patients with type 2 diabetes.

Metformin Use Linked with Lower Colorectal Cancer Risk

Metformin Use Linked with Lower Colorectal Cancer Risk

For patients with diabetes in the U.S., metformin use is associated with reduced risk of developing colorectal cancer (CRC).

Diabetes May Predispose Women to More Advanced Breast Cancer

Diabetes May Predispose Women to More Advanced Breast Cancer

Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer.

Metformin Does Not Reduce Lung Cancer Risk

Metformin Does Not Reduce Lung Cancer Risk

By

A large, retrospective cohort study found no evidence that metformin prevents lung cancer, although nonsmokers may find some benefit.

Increased Colorectal Cancer Risk in Patients with Type 2 Diabetes Mellitus

Increased Colorectal Cancer Risk in Patients with Type 2 Diabetes Mellitus

Increased risk of colorectal cancer for diabetes patients with obesity duration of four years or longer.

Increased Colorectal Cancer Risk in Patients with Type 2 Diabetes Mellitus

Increased Colorectal Cancer Risk in Patients with Type 2 Diabetes Mellitus

Increased risk of colorectal cancer for diabetes patients with obesity duration of four years or longer.

Protein Linked to Cancer, Diabetes Also Has Role in Pulmonary Hypertension

Protein Linked to Cancer, Diabetes Also Has Role in Pulmonary Hypertension

The protein Sirtuin3 was linked to the development of pulmonary hypertension.

Higher Lipoprotein Cholesterol May Protect Against Cancer

Higher Lipoprotein Cholesterol May Protect Against Cancer

Findings based on large retrospective study of patients with type 2 diabetes.

Pancreatic Cancer Risk Not Raised with Dipeptidyl-Peptidase-4 (DPP-4) Inhibitors

Pancreatic Cancer Risk Not Raised with Dipeptidyl-Peptidase-4 (DPP-4) Inhibitors

Findings based on comparison to sulfonylureas and thiazolidinediones.

Hodgkin's Lymphoma Survivors Face Higher Diabetes Risk

Hodgkin's Lymphoma Survivors Face Higher Diabetes Risk

Para-aortic radiation with ≥36 Gy linked to increased risk of diabetes mellitus.

Transformation of White Fat to Brown Fat Drives Cachexia

Transformation of White Fat to Brown Fat Drives Cachexia

By

Changes in adipose tissue precede the development of cachexia symptoms, and suggest a treatment approach.

Diabetes Raises Risk of Head and Neck Cancer

Diabetes Raises Risk of Head and Neck Cancer

Retrospective cohort study in Taiwan shows significantly increased risk of cancer.

Metformin Fails to Decrease Bladder Cancer Risk

Metformin Fails to Decrease Bladder Cancer Risk

Metformin doesn't significantly reduce risk of bladder cancer in patients with type 2 diabetes.

Insulin Sensitizers Decrease Cancer Risk in Women with Diabetes

Insulin Sensitizers Decrease Cancer Risk in Women with Diabetes

In women with type 2 diabetes, thiazolidinediones found particularly protective

No Link Found Between Breast Cancer and Insulins

No Link Found Between Breast Cancer and Insulins

An international study that examined short- to mid-term use of various insulins in patients with diabetes found no increased risk of breast cancer.

Study Backs Benefits of Metformin in Prostate Cancer

Study Backs Benefits of Metformin in Prostate Cancer

Increased cumulative duration of metformin after a prostate cancer diagnosis correlates with decreased mortality in elderly men with diabetes.

Insulin Glargine Doesn't Pose Cancer Risk

Insulin Glargine Doesn't Pose Cancer Risk

There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn insulin.

GLP-1 Analogs and Their Ties to Pancreatic Cancer

GLP-1 Analogs and Their Ties to Pancreatic Cancer

By

Drugs designed to treat diabetes may also increase patients' risk for pancreatic cancer.

Relationship of Type 2 Diabetes and Cancer Risk

Relationship of Type 2 Diabetes and Cancer Risk

By

For more than 50 years, an association between diabetes and an increased risk for cancer has been recognized and supported in numerous studies.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs